MJH Life Sciences™ Announces Partnership with Global Liver Institute

CRANBURY, N.J., April 20, 2021 /PRNewswire/ -- MJH Life Sciences™, the privately-owned health care media company, is excited to officially announce that it has expanded its Strategic Alliance Partnership (SAP) program with the addition of the Global Liver Institute (GLI), a collaborative and innovative platform for the entire spectrum of liver diseases and liver health advocates. This latest partnership with the MJH Life Sciences™ portfolio strengthens its position in the oncology space, joining CURE®, OncLive®, and Targeted Oncology™.

"We are so proud to be uniting with GLI," said Mike Hennessy Jr., president and CEO of MJH Life Sciences™. "With its esteemed board of directors and expert staff, I am confident this partnership will foster collaboration and innovation between each of our brands as they all work toward their common goal of improving the quality of patient care."

GLI is a nonprofit organization based in Washington, D.C. With the mission of improving the lives of individuals and families impacted by liver disease, GLI promotes innovation, encourages collaboration and scales optimal approaches to help eradicate these diseases. With a focus on the areas of autoimmune, transplant, cancer, nonalcoholic steatohepatitis and fatty liver disease, pediatric and viral liver health, GLI covers a wide range of liver care, offering support and resources to as many patients as possible.

"GLI is honored to partner with MJH Life Sciences, an organization who shares our commitment to delivering trusted health care news and information to improve patient outcomes," said Donna R. Cryer, president and CEO of GLI. "As we combine our strengths and strategic insights, we look forward to working together to further expand the reach of our liver cancer programs and Liver Cancers Council. Our partnership with MJH will enable us to share our resources such as GLI's Liver Cancer Lessons and other materials. Our ultimate goal is to improve the lives of patients living with liver cancer as well as their care partners and ease their journey along the way."

The SAP program partners leading medical associations, health plans, advocacy groups and medical institutions with each other for national reach and visibility. By utilizing the MJH Life Sciences™ communication platform, these groups can showcase cutting-edge initiatives, content, research and thought leadership. The SAP program also fosters collaboration and an open exchange of information among trusted peers for the benefit of patients and their families. As part of this joint effort, CURE®, OncLive®, and Targeted Oncology™ will work with GLI to share information and will help transform the fight against liver disease.

For a full list of CURE Media Group's SAP partners, click here.

For a full list of OncLive® SAP partners, click here.

For a full list of Targeted Oncology™ SAP partners, click here.

For more information on GLI, click here.

About MJH Life Sciences™
MJH Life Sciences™ is the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes. MJH combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, please visit https://www.mjhlifesciences.com/.

About Global Liver Institute
Global Liver Institute (GLI) is a 501(c)(3) tax-exempt not-for-profit organization headquartered in Washington, D.C., with offices in the United States and Europe. GLI's vision is for liver health to take its place in the global public health agenda commensurate with its prevalence and impact. GLI's mission is to improve the lives of individuals and families impacted by liver disease through promoting innovation, encouraging collaboration, and supporting the scaling of optimal approaches to help eradicate liver diseases. Follow us on Twitter, Facebook, Instagram and LinkedIn.

MJH Life Sciences™ Media Contact
Alexandra Ventura, 609-716-7777
[email protected]

SOURCE MJH Life Sciences